Telstar consolidates a new high-standard process R+D laboratory service in China


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Telstar consolidates a new high-standard process R+D laboratory service in China
The company has experienced an evolving increased presence of Telstar GMP freeze-dryers in China and currently let customers a complete support laboratory service

Through an innovative sterilization & freeze-drying processes R&D laboratory, Telstar offers pharmaceutical companies located in China a qualified and complete consultancy service for the development, qualification and validation of process cycles, simplifying the assessment of a product's behaviour before the freeze drying or sterilization process, as well as adapting and optimizing the process before its industrial implementation. Formally established in January 2020, the new service has undergone a substantial demand for growth with more than 30 companies and hundreds of specialists who have displayed their interest in the new service and some tests have been developed in many cases, during this period.

Referent in freeze drying recipe development in the laboratory field in China, the new installation is equipped with all the necessary testing and analysis equipment for freeze drying process development, high configuration Telstar pilot freeze dryer, freezing microscope and residential moisture analyser, among others. The new service reinforces Telstar’s capacity to offer a more stable and locally support to pharmaceutical companies.

The company has experienced an evolving increased presence of Telstar GMP freeze-dryers in China and currently let customers a complete support laboratory service to develop & improve recipes and test of samples and new developments prior to the process of production.

The company has had a presence in China since 1998 and has become a key player in the region. With a 4,500-m2 production plant located in the district of Nanhui Pudong, in Shanghai, Telstar in China is highly specialized in the design and manufacture of processing equipment. The factory provides support for the development of equipment and integrated process solutions for the international life sciences market and particularly for the Asia-Pacific region’s pharmaceutical sector. Particularly focused on the management of projects for freeze-drying technologies, specialized in manufacturing of lyophilizer loading and unloading systems, the subsidiary of Telstar in China has the mission of responding to the high potential of the pharma market in Asia-Pacific region besides providing local support to customers.

Tags : #Telstar #LatestNewsonTelstar24thNov #LatestPharmaNews24thNov #Sanghai #China #InnovativeSterilizationProcess #GMPFreeze-Dryers

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026